| Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesicles N Ludwig, A Rao, P Sandlesh, SS Yerneni, AD Swain, KM Bullock, ... Neuro-oncology 24 (2), 197-209, 2022 | 27 | 2022 |
| In vivo efficacy of decitabine as a natural killer cell–mediated immunotherapy against isocitrate dehydrogenase mutant gliomas X Zhang, WJ Kim, AV Rao, E Jaman, CP Deibert, P Sandlesh, K Krueger, ... Neurosurgical Focus 52 (2), E3, 2022 | 6 | 2022 |
| All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axis A Rao, X Zhang, A Cillo, JH Sussman, P Sandlesh, AC Tarbay, ... bioRxiv, 2024.04. 09.588752, 2024 | | 2024 |
| TMIC-22. IDENTIFICATION OF EXOSOME MIRNA-MRNA INTERACTIONS IN THE GLIOMA TUMOR IMMUNE MICROENVIRONMENT E Xu, K Krueger, J Sussman, E Akca, IM Matache, A Halthore, J Patterson, ... Neuro-Oncology 25 (Supplement_5), v282-v283, 2023 | | 2023 |
| ALL-TRANS RETINOIC ACID INDUCES DURABLE TUMOR IMMUNITY IN IDH MUTANT GLIOMAS AND CIRCUMVENTS REPRESSION OF CRBP1-RETINOIC ACID AXIS X Zhang, A Rao, A Cillo, A Mallela, K Krueger, T Bruno, N Amankulor NEURO-ONCOLOGY 24, 287-287, 2022 | | 2022 |
